FDA Adverse Event Death Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1714139 · Received June 7, 2010

Report

Report Number
2024168-2010-01125
Event Type
Death
Date Received
June 7, 2010
Date of Event
April 17, 2010
Report Date
May 13, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4). (B) (4). THE 4.0 X 28MM XIENCE V SENT MENTIONED IS BEING REPORTED UNDER THIS SAME MEDWATCH REPORT NUMBER. THE 2.5 X 8MM XIENCE V STENT MENTIONED IS BEING REPORTED UNDER A SEPARATE MEDWATCH REPORT NUMBER. IN THIS CASE, THERE WAS NO REPORTED DEFICIENCY. DEATH IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

DEVICE ISSUE: NONE. ADVERSE EVENT: DEATH. TIME OF ADVERSE EVENT: APPROXIMATELY 16 MONTHS POST PROCEDURE. IT WAS REPORTED VIA A TRIAL THAT ON (B) (6) 2008, THE PT UNDERWENT STENTING OF THE PRE-DILATED MID LEFT ANTERIOR DESCENDING ARTERY WITH A 2.5 X 8 RX XIENCE V STENT AND THE PRE-DILATED PROXIMAL RIGHT CORONARY ARTERY WITH A 4.0 X 12 OTW XIENCE V STENT AND 4.0 X 28 OTW XIENCE V STENT. ON (B) (6) 2010, THE PT EXPIRED. DETAILS SURROUNDING THE DEATH ARE UNK. THE CAUSE OF DEATH LISTED ON THE DEATH CERTIFICATE IS DEMENTIA. NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8031161

Patients

Seq Age Sex Outcome Treatment
1 80 YR Death (P.N. 1009549-28, LOT# 7113061)| 2.5 X 8 MM XIENCE V (P.N. 1009539-08, LOT#7101641)| 4.0 X 28 MM XIENCE V: